A detailed history of Wealthspire Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 55,754 shares of ABBV stock, worth $10 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
55,754
Previous 49,673 12.24%
Holding current value
$10 Million
Previous $8.52 Million 29.24%
% of portfolio
0.11%
Previous 0.11%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $996,311 - $1.21 Million
6,081 Added 12.24%
55,754 $11 Million
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $559,565 - $653,447
-3,615 Reduced 6.78%
49,673 $8.52 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $322,516 - $367,477
-2,018 Reduced 3.65%
53,288 $9.7 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $24,355 - $27,429
-177 Reduced 0.32%
55,306 $8.57 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $1.21 Million - $1.4 Million
9,072 Added 19.55%
55,483 $8.27 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $73,013 - $90,859
-551 Reduced 1.17%
46,411 $6.25 Million
Q1 2023

May 09, 2023

SELL
$144.61 - $166.54 $557,182 - $641,678
-3,853 Reduced 7.58%
46,962 $7.48 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $356,563 - $427,612
2,578 Added 5.34%
50,815 $8.22 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $59,857 - $68,652
446 Added 0.93%
48,237 $6.47 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $433,915 - $551,648
3,153 Added 7.06%
47,791 $7.32 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $1.38 Million - $1.71 Million
-10,433 Reduced 18.94%
44,638 $7.24 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $3.76 Million - $4.76 Million
35,007 Added 174.48%
55,071 $7.46 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $1.14 Million - $1.3 Million
10,739 Added 115.16%
20,064 $2.16 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $2.87 Million - $3.2 Million
-27,263 Reduced 74.51%
9,325 $1.05 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $684,796 - $753,878
6,694 Added 22.39%
36,588 $3.96 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $930,866 - $1.26 Million
-11,565 Reduced 27.9%
29,894 $3.2 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $385,392 - $452,323
4,486 Added 12.13%
41,459 $3.63 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $292,012 - $390,756
3,980 Added 12.06%
36,973 $3.63 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $1.5 Million - $2.27 Million
23,205 Added 237.08%
32,993 $2.51 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $89,801 - $112,361
1,245 Added 14.57%
9,788 $867,000
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $283,850 - $341,270
4,507 Added 111.67%
8,543 $647,000
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $265,165 - $338,943
4,036 New
4,036 $293,000
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $135,534 - $159,518
-1,757 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $136,782 - $168,689
1,757 New
1,757 $162,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealthspire Advisors, LLC Portfolio

Follow Wealthspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.